GLS and rheumatoid arthritis: have demonstrated that lncRNA NEAT1 enhances glutamine metabolism in RA-FLSs by sponging miR-338-3p, thereby relieving its inhibitory effect on the target gene GLS; this highlights that lncRNA NEAT1-driven metabolic reprogramming is a promising therapeutic target for RA (70).